Orange Book product · Brand (NDA)
MELOXICAM
MELOXICAM
At a glance
Jun 01, 2004
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 01, 2004
22 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
MELOXICAM
Strength
7.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
SUSPENSION
Route
ORAL
TE code
Not listed
Application
NDA 021530
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025XIFYRMBrand (NDA)
NDA 218395 · AZURITY
- 2025QAMZOVABrand (NDA)
NDA 217593 · NANJING DELOVA
- 2020ANJESOBrand (NDA)
NDA 210583 · BAUDAX
- 2018QMIIZ ODTBrand (NDA)
NDA 211210 · TERSERA
- 2015VIVLODEXBrand (NDA)
NDA 207233 · ICEUTICA OPERATIONS
- 2000MOBICBrand (NDA)
NDA 020938 · BOEHRINGER INGELHEIM
- 2023MELOXICAMGeneric (ANDA)
ANDA 217579 · ASCENT PHARMS INC
- 2021MELOXICAMGeneric (ANDA)
ANDA 211398 · NOVITIUM PHARMA
- 2020MELOXICAMGeneric (ANDA)
ANDA 209487 · LUPIN
- 2009MELOXICAMGeneric (ANDA)
ANDA 077928 · NOVITIUM PHARMA
- 2006MELOXICAMGeneric (ANDA)
ANDA 077927 · UNICHEM
- 2006MELOXICAMGeneric (ANDA)
ANDA 078039 · CR DOUBLE CRANE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
